Kenneth A. Newlander

Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2

Sharad K. Verma, Xinrong Tian, Louis V. LaFrance et al. · ACS Medicinal Chemistry Letters · 2012 · 373 citations · Full text

Histone Modifications, Drug Discovery Program, Engineering +18

Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents

David Payne, William H. Miller, Valerie Berry et al. · Antimicrobial Agents and Chemotherapy · 2002 · 163 citations · Full text

Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK

Mark A. Seefeld, William H. Miller, Kenneth A. Newlander et al. · Journal of Medicinal Chemistry · 2003 · 161 citations · Full text

Bioorganic Chemistry, Chemical Biology, Pharmaceutical Chemistry +20

Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic

William H. Miller, Doreen Alberts, Pradip K. Bhatnagar et al. · Journal of Medicinal Chemistry · 1999 · 116 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Pharmacodynamic Modeling +16

Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI)

William H. Miller, Mark A. Seefeld, Kenneth A. Newlander et al. · Journal of Medicinal Chemistry · 2002 · 109 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Bioorganic Chemistry +15